RPTX
Repare Therapeutics
RPTX
RPTX
Delisted
RPTX was delisted on the 27th of January, 2026.
78 hedge funds and large institutions have $379M invested in Repare Therapeutics in 2023 Q2 according to their latest regulatory filings, with 8 funds opening new positions, 23 increasing their positions, 25 reducing their positions, and 7 closing their positions.
New
Increased
Maintained
Reduced
Closed
more funds holding in top 10
Funds holding in top 10: →
more capital invested
Capital invested by funds: $ → $
more first-time investments, than exits
New positions opened: | Existing positions closed:
more ownership
Funds ownership: →
1% more funds holding
Funds holding: 77 → 78 (+1)
8% less repeat investments, than reductions
Existing positions increased: 23 | Existing positions reduced: 25
35% less call options, than puts
Call options by funds: $87K | Put options by funds: $133K
Holders
78
Holding in Top 10
5
Calls
$87K
Puts
$133K
Top Buyers
| 1 | +$27.3M | |
| 2 | +$2.55M | |
| 3 | +$2.11M | |
| 4 |
Ensign Peak Advisors
Salt Lake City,
Utah
|
+$1.92M |
| 5 |
NAMA
Nikko Asset Management Americas
New York
|
+$1.66M |
Top Sellers
| 1 | -$3.1M | |
| 2 | -$1.57M | |
| 3 | -$1.33M | |
| 4 |
AIM
ARK Investment Management
St. Petersburg,
Florida
|
-$1.13M |
| 5 |
RG
Redmile Group
San Francisco,
California
|
-$1.08M |